Mereo BioPharma Group PLCNASDAQ:MREO
- LAST PRICE4.8300
- TODAY'S CHANGE (%)0.3200 (7.0953%)
- Bid / Lots4.8500/ 1
- Ask / Lots4.9000/ 5
- Open / Previous Close4.6200 / 4.5100
- Day Range
- 52 Week Range
- Volume1,896,113
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MREO |
|---|---|---|
| 09:32 ET | 75434 | 4.705 |
| 09:34 ET | 34634 | 4.8 |
| 09:36 ET | 42636 | 4.8 |
| 09:38 ET | 18011 | 4.795 |
| 09:39 ET | 15620 | 4.772 |
| 09:41 ET | 42855 | 4.825 |
| 09:43 ET | 3750 | 4.7883 |
| 09:45 ET | 12581 | 4.7705 |
| 09:48 ET | 20036 | 4.785 |
| 09:50 ET | 30890 | 4.885 |
| 09:52 ET | 19171 | 4.875 |
| 09:54 ET | 21384 | 4.89 |
| 09:56 ET | 44188 | 4.8876 |
| 09:57 ET | 40263 | 4.8951 |
| 09:59 ET | 12765 | 4.885 |
| 10:01 ET | 11169 | 4.94 |
| 10:03 ET | 44638 | 4.9332 |
| 10:06 ET | 22688 | 4.98 |
| 10:08 ET | 44304 | 4.92 |
| 10:10 ET | 27836 | 4.94 |
| 10:12 ET | 14515 | 4.96 |
| 10:14 ET | 5881 | 4.995 |
| 10:15 ET | 41395 | 5.0099 |
| 10:17 ET | 5100 | 5.0158 |
| 10:19 ET | 23578 | 4.95 |
| 10:21 ET | 20836 | 4.925 |
| 10:24 ET | 19064 | 4.92 |
| 10:26 ET | 20676 | 4.91 |
| 10:28 ET | 13619 | 4.9101 |
| 10:30 ET | 25827 | 4.9101 |
| 10:32 ET | 4597 | 4.915 |
| 10:33 ET | 3704 | 4.92 |
| 10:35 ET | 5536 | 4.92 |
| 10:37 ET | 11286 | 4.915 |
| 10:39 ET | 9806 | 4.92 |
| 10:42 ET | 11271 | 4.92 |
| 10:44 ET | 17023 | 4.92 |
| 10:46 ET | 3400 | 4.91 |
| 10:48 ET | 5160 | 4.915 |
| 10:50 ET | 20420 | 4.8525 |
| 10:51 ET | 27137 | 4.8513 |
| 10:53 ET | 14654 | 4.83 |
| 10:55 ET | 5300 | 4.83 |
| 10:57 ET | 8197 | 4.8506 |
| 11:00 ET | 7355 | 4.8899 |
| 11:02 ET | 9356 | 4.9 |
| 11:04 ET | 7033 | 4.914 |
| 11:06 ET | 7250 | 4.925 |
| 11:08 ET | 6063 | 4.945 |
| 11:09 ET | 1335 | 4.95 |
| 11:11 ET | 2004 | 4.93 |
| 11:13 ET | 8503 | 4.88 |
| 11:15 ET | 2879 | 4.88 |
| 11:18 ET | 4028 | 4.88 |
| 11:20 ET | 6082 | 4.86 |
| 11:22 ET | 4695 | 4.85 |
| 11:24 ET | 8988 | 4.855 |
| 11:26 ET | 6259 | 4.855 |
| 11:27 ET | 28586 | 4.86 |
| 11:29 ET | 660 | 4.87 |
| 11:31 ET | 102 | 4.875 |
| 11:33 ET | 1637 | 4.8701 |
| 11:36 ET | 3264 | 4.88 |
| 11:38 ET | 1146 | 4.8882 |
| 11:40 ET | 12137 | 4.93 |
| 11:42 ET | 7252 | 4.97 |
| 11:44 ET | 100 | 4.97 |
| 11:45 ET | 16470 | 4.9403 |
| 11:47 ET | 6050 | 4.92 |
| 11:49 ET | 20261 | 4.95 |
| 11:51 ET | 4124 | 4.9398 |
| 11:54 ET | 3462 | 4.93 |
| 11:56 ET | 3207 | 4.915 |
| 11:58 ET | 7379 | 4.92 |
| 12:00 ET | 10679 | 4.895 |
| 12:02 ET | 14597 | 4.86 |
| 12:03 ET | 6825 | 4.86 |
| 12:05 ET | 10977 | 4.85 |
| 12:07 ET | 1854 | 4.85 |
| 12:09 ET | 7205 | 4.85 |
| 12:12 ET | 30934 | 4.79 |
| 12:14 ET | 7304 | 4.79 |
| 12:16 ET | 8239 | 4.79 |
| 12:18 ET | 10461 | 4.8 |
| 12:20 ET | 5677 | 4.7945 |
| 12:21 ET | 14720 | 4.7901 |
| 12:23 ET | 2744 | 4.795 |
| 12:25 ET | 8695 | 4.79 |
| 12:27 ET | 1400 | 4.795 |
| 12:30 ET | 6745 | 4.82 |
| 12:32 ET | 1475 | 4.835 |
| 12:34 ET | 2200 | 4.8394 |
| 12:36 ET | 600 | 4.845 |
| 12:38 ET | 1420 | 4.85 |
| 12:39 ET | 100 | 4.855 |
| 12:43 ET | 15918 | 4.81 |
| 12:45 ET | 2850 | 4.82 |
| 12:48 ET | 2240 | 4.83 |
| 12:50 ET | 8343 | 4.81 |
| 12:52 ET | 1800 | 4.81 |
| 12:54 ET | 599 | 4.82 |
| 12:56 ET | 500 | 4.82 |
| 12:57 ET | 9199 | 4.79 |
| 12:59 ET | 1100 | 4.795 |
| 01:01 ET | 5250 | 4.79 |
| 01:03 ET | 1520 | 4.79 |
| 01:06 ET | 708 | 4.79 |
| 01:08 ET | 2811 | 4.77 |
| 01:10 ET | 6762 | 4.76 |
| 01:12 ET | 2429 | 4.75 |
| 01:14 ET | 16199 | 4.72 |
| 01:15 ET | 1629 | 4.725 |
| 01:17 ET | 9300 | 4.72 |
| 01:19 ET | 1299 | 4.725 |
| 01:24 ET | 1455 | 4.725 |
| 01:26 ET | 15292 | 4.72 |
| 01:28 ET | 5872 | 4.72 |
| 01:30 ET | 4653 | 4.7278 |
| 01:32 ET | 450 | 4.7287 |
| 01:33 ET | 5955 | 4.725 |
| 01:35 ET | 3290 | 4.7101 |
| 01:37 ET | 2502 | 4.71 |
| 01:39 ET | 3200 | 4.71 |
| 01:42 ET | 3000 | 4.71 |
| 01:44 ET | 17149 | 4.725 |
| 01:46 ET | 14448 | 4.77 |
| 01:48 ET | 8401 | 4.75 |
| 01:50 ET | 1484 | 4.75 |
| 01:51 ET | 5656 | 4.75 |
| 01:53 ET | 4394 | 4.79 |
| 01:55 ET | 3650 | 4.82 |
| 01:57 ET | 2918 | 4.825 |
| 02:00 ET | 350 | 4.825 |
| 02:02 ET | 3468 | 4.81 |
| 02:04 ET | 1435 | 4.81 |
| 02:06 ET | 450 | 4.815 |
| 02:08 ET | 856 | 4.81 |
| 02:09 ET | 1069 | 4.8099 |
| 02:11 ET | 118 | 4.805 |
| 02:13 ET | 1508 | 4.795 |
| 02:15 ET | 1028 | 4.8098 |
| 02:18 ET | 3400 | 4.7999 |
| 02:20 ET | 750 | 4.7948 |
| 02:22 ET | 918 | 4.79 |
| 02:24 ET | 4956 | 4.775 |
| 02:26 ET | 6298 | 4.79 |
| 02:27 ET | 1200 | 4.795 |
| 02:29 ET | 3572 | 4.775 |
| 02:31 ET | 2287 | 4.79 |
| 02:33 ET | 222 | 4.7999 |
| 02:36 ET | 3435 | 4.77 |
| 02:38 ET | 1908 | 4.78 |
| 02:40 ET | 5334 | 4.7901 |
| 02:42 ET | 5399 | 4.79 |
| 02:44 ET | 7027 | 4.805 |
| 02:45 ET | 200 | 4.8068 |
| 02:47 ET | 1110 | 4.805 |
| 02:49 ET | 1200 | 4.81 |
| 02:51 ET | 2017 | 4.82 |
| 02:54 ET | 5849 | 4.82 |
| 02:56 ET | 912 | 4.814 |
| 02:58 ET | 875 | 4.81 |
| 03:00 ET | 4150 | 4.8099 |
| 03:02 ET | 338 | 4.8078 |
| 03:03 ET | 1200 | 4.805 |
| 03:05 ET | 100 | 4.805 |
| 03:07 ET | 5096 | 4.78 |
| 03:09 ET | 191 | 4.78 |
| 03:12 ET | 900 | 4.785 |
| 03:14 ET | 5327 | 4.805 |
| 03:16 ET | 3971 | 4.805 |
| 03:18 ET | 2600 | 4.8097 |
| 03:20 ET | 1602 | 4.815 |
| 03:21 ET | 3245 | 4.825 |
| 03:23 ET | 5530 | 4.8399 |
| 03:25 ET | 8500 | 4.85 |
| 03:27 ET | 6090 | 4.84 |
| 03:30 ET | 2736 | 4.835 |
| 03:32 ET | 6246 | 4.84 |
| 03:34 ET | 4240 | 4.815 |
| 03:36 ET | 4672 | 4.815 |
| 03:38 ET | 11703 | 4.805 |
| 03:39 ET | 21210 | 4.825 |
| 03:41 ET | 27025 | 4.8299 |
| 03:43 ET | 8261 | 4.8 |
| 03:45 ET | 1387 | 4.79 |
| 03:48 ET | 13653 | 4.81 |
| 03:50 ET | 3253 | 4.8 |
| 03:52 ET | 3090 | 4.805 |
| 03:54 ET | 1543 | 4.8 |
| 03:56 ET | 3630 | 4.805 |
| 03:57 ET | 9079 | 4.815 |
| 03:59 ET | 57404 | 4.83 |
Aug 13, 2024
DJ Mereo BioPharma Group Price Target Maintained With a $7.00/Share by Needham, from 2:06PM ET on Tuesday Aug 13, 2024 by Dow Jones
2:06PM ET on Tuesday Aug 13, 2024 by Dow JonesMereo BioPharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update, from 8:00AM ET on Tuesday Aug 13, 2024 by Dow Jones
8:00AM ET on Tuesday Aug 13, 2024 by Dow JonesPress Release: Mereo BioPharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update, from 8:00AM ET on Tuesday Aug 13, 2024 by Dow Jones
8:00AM ET on Tuesday Aug 13, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Mereo BioPharma Group PLC | 743.1M | -14.7x | --- |
Tarsus Pharmaceuticals Inc | 971.2M | -5.8x | --- |
Immunome Inc | 927.8M | -2.7x | --- |
Relay Therapeutics Inc | 964.0M | -2.9x | --- |
Viridian Therapeutics Inc | 961.5M | -3.5x | --- |
89Bio Inc | 937.8M | -4.5x | --- |
Company Information
Mereo BioPharma Group plc is a biopharmaceutical company. It is focused on the development of therapeutics for rare diseases. It has developed a portfolio of clinical-stage product candidates. The Company has two rare disease product candidates: setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat for the treatment of severe alpha-1-antitrypsin deficiency-associated lung disease (AATD-LD) and bronchiolitis obliterans syndrome (BOS). It also has two oncology product candidates in clinical development. It also includes Etigilimab, an antibody against TIGIT (T-cell immunoreceptor with Ig and ITIM domains). Its non-core partnered programme, Navicixizumab, is a bispecific antibody that inhibits delta-like ligand 4 (DLL4) and vascular endothelial growth factor (VEGF). Its non-core programs available for partnership include Acumapimod and Leflutrozole. Acumapimod is a p38 MAP kinase inhibitor therapy for treatment during severe acute exacerbations of COPD (AECOPD).
Contact Information
- Headquarters
- One Cavendish Place, Fourth FloorLONDON, United Kingdom W1G0QF
- Phone
- ---
- Fax
- ---
Executives
- Non-Executive Independent Chairman of the Board
- Michael Wyzga
- Chief Executive Officer, Director
- Denise Scots-Knight
- Chief Financial Officer
- Christine Fox
- Senior Vice President - Clinical Development
- Suba Krishnan
- Senior Vice President - Therapeutic Head
- Jackie Parkin
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $743.1M |
|---|---|
Revenue (TTM) | $10.5M |
Shares Outstanding | 153.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.97 |
EPS | $-0.33 |
Book Value | $0.46 |
P/E Ratio | -14.7x |
Price/Sales (TTM) | 71.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -416.58% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
